DJIA 17,596.35 0.00 0.00%
NASDAQ 4,958.47 0.00 0.00%
S&P 500 2,057.64 0.00 0.00%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

11.54 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $12.15 $0.61 (5.29%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ZIOP $11.54 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $11.54
Daily Range $0.00 - $0.00
52-Week Range $2.31 - $14.40
Market Cap $1.5B
P/E Ratio -12.82
Dividend (Yield) $0.00 (0.0%)
Volume 300
Average Daily Volume 3,359,294
Current FY EPS -$0.43

Sector

Healthcare

Industry

Drug Makers

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary

What Is Cancer Immunotherapy?

Cancer immunotherapy is rapidly becoming a major new weapon in the fight against this deadly disease. Here is a brief primer on this powerful new technology, as well as a look at where it's likely headed moving forward.

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Post-Market Leader Stock

Intrexon Corp is expanding its business

Intrexon Corp is expanding his business

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will ZIOPHARM Oncology (ZIOP) Stock Decline After Analyst Downgrade?

Barbarian At The Gate: ZIOPHARM Oncology (ZIOP)

Ziopharm Oncology Downgraded By BMO As 'Questions Persist'

CAR T-Cell Biotechs Look Exciting, But A Word Of Caution On Safety

Perilous Reversal Stock: ZIOPHARM Oncology (ZIOP)

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $11.54 (0.00%)
Current stock: ZIOP
AMGN $151.60 (0.00%)
Current stock: AMGN
GILD $115.46 (0.00%)
Current stock: GILD
BIIB $396.21 (0.00%)
Current stock: BIIB